The live-attenuated vaccine, VSV-EBOV, uses genetically engineered Vesicular stomatitis virus to carry an EBOV gene that has safely induced protective immunity in Cynomolgus macaques (monkey)
against EBOV-Makona (virus) strain. The experimental vaccine is
currently undergoing testing in a global clinical trial in humans.
Ref: A Marzi et al., 2015, Science.
No comments:
Post a Comment